WallStSmart

Cabot Corporation (CBT)vsUSA Rare Earth, Inc. (USAR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cabot Corporation generates 48599% more annual revenue ($3.58B vs $7.34M). CBT leads profitability with a 8.0% profit margin vs 0.0%. CBT earns a higher WallStSmart Score of 57/100 (C).

CBT

Buy

57

out of 100

Grade: C

Growth: 2.0Profit: 7.0Value: 6.0Quality: 6.0
Piotroski: 4/9Altman Z: 2.87

USAR

Avoid

28

out of 100

Grade: F

Growth: 4.3Profit: 2.5Value: 5.0Quality: 6.5
Piotroski: 2/9Altman Z: -0.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBTSignificantly Overvalued (-56.4%)

Margin of Safety

-56.4%

Fair Value

$48.54

Current Price

$84.54

$36.00 premium

UndervaluedFair: $48.54Overvalued

Intrinsic value data unavailable for USAR.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBT3 strengths · Avg: 8.0/10
PEG RatioValuation
1.008/10

Growing faster than its price suggests

P/E RatioValuation
16.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

USAR2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

CBT3 concerns · Avg: 2.3/10
Profit MarginProfitability
8.0%3/10

8.0% margin — thin

Revenue GrowthGrowth
-3.4%2/10

Revenue declined 3.4%

EPS GrowthGrowth
-24.9%2/10

Earnings declined 24.9%

USAR4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CBT

The strongest argument for CBT centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : USAR

The strongest argument for USAR centers on Debt/Equity, Price/Book.

Bear Case : CBT

The primary concerns for CBT are Profit Margin, Revenue Growth, EPS Growth.

Bear Case : USAR

The primary concerns for USAR are Revenue Growth, EPS Growth, Profit Margin.

Key Dynamics to Monitor

USAR carries more volatility with a beta of 2.48 — expect wider price swings.

USAR is growing revenue faster at 0.0% — sustainability is the question.

CBT generates stronger free cash flow (32M), providing more financial flexibility.

Monitor SPECIALTY CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CBT scores higher overall (57/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cabot Corporation

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Cabot Corporation (CBT) is a premier global provider of specialty chemicals and performance materials, recognized for its innovative solutions that enhance sustainability across diverse industries such as automotive, electronics, and coatings. The company specializes in manufacturing high-quality carbon black and specialty compounds while implementing advanced recovery solutions, underpinned by a strong emphasis on research and development. Committed to operational excellence and environmental stewardship, Cabot Corporation not only leads in setting sustainable industry standards but also forms strategic partnerships with customers to deliver advanced materials that address their dynamic requirements.

Visit Website →

USA Rare Earth, Inc.

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

USA Rare Earth, Inc. engages in mining, processing, and supplying rare earths and other critical minerals. The company is headquartered in Stillwater, Oklahoma.

Want to dig deeper into these stocks?